Reviewing Hims & Hers Health (NYSE:HIMS) & Basel Medical Group (NASDAQ:BMGL)
by Tristan Rich · The Markets DailyBasel Medical Group (NASDAQ:BMGL – Get Free Report) and Hims & Hers Health (NYSE:HIMS – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.
Risk and Volatility
Basel Medical Group has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for Basel Medical Group and Hims & Hers Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Basel Medical Group | 1 | 0 | 0 | 0 | 1.00 |
| Hims & Hers Health | 1 | 11 | 4 | 0 | 2.19 |
Hims & Hers Health has a consensus price target of $32.50, indicating a potential upside of 14.24%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Basel Medical Group.
Profitability
This table compares Basel Medical Group and Hims & Hers Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Basel Medical Group | N/A | N/A | N/A |
| Hims & Hers Health | -5.51% | -6.51% | -1.20% |
Insider & Institutional Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Basel Medical Group and Hims & Hers Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Basel Medical Group | $8.90 million | 0.89 | -$9.50 million | N/A | N/A |
| Hims & Hers Health | $2.35 billion | 2.83 | $128.37 million | ($0.63) | -45.16 |
Hims & Hers Health has higher revenue and earnings than Basel Medical Group.
Summary
Hims & Hers Health beats Basel Medical Group on 9 of the 12 factors compared between the two stocks.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.